Celldex Therapeutics (CLDX) Interest Coverage Ratio (QoQ) (2010 - 2013)
Powered by 
Analysis
Celldex Therapeutics (CLDX) Interest Coverage Ratio (QoQ) (2010 - 2013) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.10 Bn | 3.10 Bn | -2.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 85.47% |
| Sep 30, 2013 | -4,878.94% |
| Jun 30, 2013 | 35.96% |
| Mar 31, 2013 | -19.05% |
| Dec 31, 2012 | -21.79% |
| Sep 30, 2012 | -17.98% |
| Jun 30, 2012 | -6.94% |
| Mar 31, 2012 | -8.55% |
| Dec 31, 2011 | -7.88% |
| Sep 30, 2011 | -15.10% |
| Jun 30, 2011 | -14.33% |
| Mar 31, 2011 | -131.59% |
| Dec 31, 2010 | 335.69% |
| Sep 30, 2010 | 3.81% |